ACM
AZN icon

Americafirst Capital Management’s AstraZeneca AZN Stock Holding History

Americafirst Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,258
Closed -$511K – 258
2014
Q4 		$511K Buy
+7,258
New +$520K 0.25% 156

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Americafirst Capital Management's AZN Position: Q1 2015 in Review

Americafirst Capital Management sold out of AstraZeneca (AZN) in Q1 2015, closing a stake of 7,258 shares — an estimated $511K sold.

Americafirst Capital Management first reported a position in AZN in Q4 2014 and held it in 1 quarter. The position peaked at $511K in Q4 2014. 386 funds tracked by Wall St. Rank hold AZN as of Q1 2015.

  • Americafirst Capital Management reported no remaining AstraZeneca position as of Q1 2015 after selling out during the quarter.
  • Americafirst Capital Management sold 7,258 AstraZeneca shares in Q1 2015, an estimated $511K.
  • Americafirst Capital Management first reported a position in AstraZeneca in Q4 2014 and held it in 1 quarter.
  • Americafirst Capital Management's AstraZeneca position peaked at $511K in Q4 2014.
  • 386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2015.

Based on Americafirst Capital Management's 13F filing for Q1 2015, filed 11 May 2015.